RVP 📈 Retractable Technologies - Overview
Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US76129W1053
RVP: Safety Syringes, Needles, Catheters, Blood Collection Sets, Medical Devices
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas. Web URL: https://www.retractable.com
Additional Sources for RVP Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
RVP Stock Overview
| Market Cap in USD | 18m |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| GiC Sub-Industry | Health Care Supplies |
| IPO / Inception | 2001-05-04 |
RVP Stock Ratings
| Growth 5y | -72.4% |
| Fundamental | -36.6% |
| Dividend | - |
| Rel. Strength Industry | -947 |
| Analysts | - |
| Fair Price Momentum | 0.47 USD |
| Fair Price DCF | 1.19 USD |
RVP Dividends
No Dividends PaidRVP Growth Ratios
| Growth Correlation 3m | -81.8% |
| Growth Correlation 12m | -86.9% |
| Growth Correlation 5y | -77.1% |
| CAGR 5y | -16.15% |
| CAGR/Mean DD 5y | -0.24 |
| Sharpe Ratio 12m | -1.13 |
| Alpha | -90.86 |
| Beta | 1.93 |
| Volatility | 55.99% |
| Current Volume | 94.2k |
| Average Volume 20d | 72.2k |
What is the price of RVP stocks?
As of December 28, 2024, the stock is trading at USD 0.64 with a total of 94,190 shares traded.
Over the past week, the price has changed by +2.36%, over one month by +3.84%, over three months by -11.57% and over the past year by -40.69%.
As of December 28, 2024, the stock is trading at USD 0.64 with a total of 94,190 shares traded.
Over the past week, the price has changed by +2.36%, over one month by +3.84%, over three months by -11.57% and over the past year by -40.69%.
Is Retractable Technologies a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Retractable Technologies (NYSE MKT:RVP) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -36.55 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RVP as of December 2024 is 0.47. This means that RVP is currently overvalued and has a potential downside of -26.56%.
Probably not. Based on ValueRay Fundamental Analyses, Retractable Technologies (NYSE MKT:RVP) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -36.55 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RVP as of December 2024 is 0.47. This means that RVP is currently overvalued and has a potential downside of -26.56%.
Is RVP a buy, sell or hold?
Retractable Technologies has no consensus analysts rating.
Retractable Technologies has no consensus analysts rating.
What are the forecast for RVP stock price target?
According to ValueRays Forecast Model, RVP Retractable Technologies will be worth about 0.5 in December 2025. The stock is currently trading at 0.64. This means that the stock has a potential downside of -17.19%.
According to ValueRays Forecast Model, RVP Retractable Technologies will be worth about 0.5 in December 2025. The stock is currently trading at 0.64. This means that the stock has a potential downside of -17.19%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.5 | -17.2% |